Further strengthens BaseLaunch's global pharma industry partnerships24 early-stage biotech ventures have now been supported by BaseLaunchPortfolio companies have raised over US$ 600 million
MUNICH, GERMANY / ACCESSWIRE / March 6, 2023 / EBD Group is thrilled to reunite on March 20-22, 2023 in Basel, Switzerland. After being held digitally for the last three years, leading executives from
EQS-News: EBD Group / Key word(s): Conference BIO-Europe Spring® 2023 is only a few weeks away 06.03.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE BIO-Europe Spring® 2023 is only a few weeks away Munich, Germany – March 6, 2023. EBD Gr.
/PRNewswire/ Engimmune Therapeutics AG ("Engimmune"), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, announced today the.